Hit #92

Serologicals (SERO) is being acquired by Millipore for $1.4 billion in cash. This buyout values Serological at $31.55/share, a premium of 137% over my average cost of $13.3/share.

I will have more to write about this sector soon - there are a lot more bargains in this neglected space.

For long term buy and hold owners, Millipore (MIL) is a good stock to own, especially so on any pullbacks from here.

---

Previous hit - Manugistics (#91)